These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25360318)

  • 1. Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: An observational study from Southern India.
    Larsson G; Shenoy KT; Ramasubramanian R; Thayumanavan L; Balakumaran LK; Bjune GA; Moum BA
    United European Gastroenterol J; 2014 Oct; 2(5):397-405. PubMed ID: 25360318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies.
    Larsson G; Shenoy KT; Ramasubramanian R; Thayumanavan L; Balakumaran LK; Bjune GA; Moum BA
    Infect Dis (Lond); 2015 Mar; 47(3):137-43. PubMed ID: 25522183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn's disease in patients started on antitubercular therapy.
    Sharma V; Verma S; Kumar-M P; Mandavdhare HS; Singh H; Shah J; Kalsi D; Dutta A; Mishra S; Prasad KK; Sharma AK; Dutta U
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):334-338. PubMed ID: 32796361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S; Metzner M; Wassell JJ; Yong A; Hawthorne AB
    Aliment Pharmacol Ther; 2004 Sep; 20(6):615-21. PubMed ID: 15352909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
    Costa F; Mumolo MG; Bellini M; Romano MR; Ceccarelli L; Arpe P; Sterpi C; Marchi S; Maltinti G
    Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal calprotectin in COVID-19 patients with intestinal symptoms.
    Ellakany WI; AbdelHady AM; Nassar MW; Elwafa RAHA
    Prz Gastroenterol; 2022; 17(4):332-337. PubMed ID: 36514448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding.
    Vavricka SR; Heinrich H; Buetikofer S; Breitenmoser F; Burri E; Schneider-Yin X; Barman-Aksoezen J; Biedermann L; Scharl M; Zeitz J; Rogler G; Misselwitz B; Sauter M
    United European Gastroenterol J; 2018 Aug; 6(7):1007-1014. PubMed ID: 30228888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
    Zippi M; Al Ansari N; Siliquini F; Severi C; Kagarmanova A; Maffia C; Parlanti S; Garbarino V; Maccioni F
    Clin Ter; 2010; 161(2):e53-6. PubMed ID: 20499020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2010 Aug; 45(7-8):872-7. PubMed ID: 20377469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E; Beglinger C
    Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
    Laharie D; Mesli S; El Hajbi F; Chabrun E; Chanteloup E; Capdepont M; Razaire S; de Lédinghen V; Zerbib F
    Aliment Pharmacol Ther; 2011 Aug; 34(4):462-9. PubMed ID: 21671970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.
    Cypers H; Varkas G; Beeckman S; Debusschere K; Vogl T; Roth J; Drennan MB; Lavric M; Foell D; Cuvelier CA; De Vos M; Delanghe J; Van den Bosch F; Elewaut D
    Ann Rheum Dis; 2016 Jul; 75(7):1357-62. PubMed ID: 26698844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple method for assessing intestinal inflammation in Crohn's disease.
    Tibble J; Teahon K; Thjodleifsson B; Roseth A; Sigthorsson G; Bridger S; Foster R; Sherwood R; Fagerhol M; Bjarnason I
    Gut; 2000 Oct; 47(4):506-13. PubMed ID: 10986210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral omeprazole and diclofenac intake is associated with increased faecal calprotectin levels: a randomised open-label clinical trial.
    Rendek Z; Falk M; Grodzinsky E; Kechagias S; Hjortswang H
    Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):52-58. PubMed ID: 36468569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ
    J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal calprotectin as a marker for oesophago-gastric cancer.
    Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM
    Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.